Viral hepatitis and HIV co-infection
- 1 November 2009
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 85 (1) , 303-315
- https://doi.org/10.1016/j.antiviral.2009.10.021
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature, 2009
- Hepatitis C Drug Development at a Crossroads†Hepatology, 2009
- Chronic hepatitis B: Update 2009 #Hepatology, 2009
- Monitoring during and after antiviral therapy for hepatitis B #Hepatology, 2009
- Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse TranscriptaseJournal of Biological Chemistry, 2008
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patientsHepatology, 2008
- The HBV Drug Entecavir — Effects on HIV-1 Replication and ResistanceNew England Journal of Medicine, 2007
- 11 Efficacy of standard-dose and fixed-dose induction peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) among pegylated interferon alpha-2b (12kd)/ribavirin non-responders: Interim analysis of the repeat studyJournal of Hepatology, 2006
- 8 24 Week treatment regimen with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in HCV genotype 1 or 4 ‘super-responders’Journal of Hepatology, 2006
- SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTSJournal of Hepatology, 2005